Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

The FDA approved the PD-1 inhibitor penpulimab, with two indications, for treating non-keratinizing nasopharyngeal carcinoma ...

Appendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...

Appendicectomy combined with standard medical therapy is superior to standard medical therapy alone in maintaining remission ...

The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...